TrialResearch and practice in thrombosis and haemostasis2026

Immunogenicity, safety, and efficacy of rurioctocog alfa pegol in previously untreated patients with severe hemophilia A.

Robert F Sidonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.